Skip to main content

Fragment Reweighting in Ligand-Based Virtual Screening

Buy Article:

$107.14 + tax (Refund Policy)

Many methods have developed to capture the biological similarity between two compounds for use in drug discovery. A variety of similarity metrics have introduced, Tanimoto coefficient being the most prominent. Many approaches assume that molecular fragments that are not related to the biological activity carry the same weight as the important ones. In this paper we enhance the effectiveness of Tanimoto and Bayesian inference methods for compound retrieval by using reweighted fragment. Here, a set of active reference structures were used to reweight the fragments in the reference structure. In this approach, higher weights were assigned to those fragments that occur more frequently in the set of active reference structures while others were penalized. At the end, our simulated virtual screening experiments with MDDR data sets showed that this approach significantly improved the retrieval effectiveness of ligand-based virtual screening, especially when the active molecules being sought have a high degree of structural heterogeneity.

Document Type: Research Article

Publication date: 01 September 2013

More about this publication?
  • ADVANCED SCIENCE LETTERS is an international peer-reviewed journal with a very wide-ranging coverage, consolidates research activities in all areas of (1) Physical Sciences, (2) Biological Sciences, (3) Mathematical Sciences, (4) Engineering, (5) Computer and Information Sciences, and (6) Geosciences to publish original short communications, full research papers and timely brief (mini) reviews with authors photo and biography encompassing the basic and applied research and current developments in educational aspects of these scientific areas.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content